A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID-19 pandemic.
Intern Med J
; 53(7): 1256-1260, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37092797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Immunologic Deficiency Syndromes
Limits:
Humans
Language:
En
Journal:
Intern Med J
Journal subject:
MEDICINA INTERNA
Year:
2023
Document type:
Article
Affiliation country:
Australia
Country of publication:
Australia